Peptide record

TPDB05762

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05762
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CAFPdb dbAMP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 9-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Sequence
KWRRWIRWL
Physicochemical Analysis
C69H102N22O10
ANDCEQGHMFPSTYV
RW
1399.71
12.71
4
0
5
+4
-3.00
-1.311
86.67
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
16500
1178.82
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 0
Chemical Descriptors
9
C69H102N22O10
1399.71
12.71
+4
-3.00
-1.311
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3
Evidence 2 Activity

Activity

MIC
Antibacterial
6.2 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 2
Evidence 3 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

S. aeurus

Source & Reference

dbAMP

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 4 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

li (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 5 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

F. solani

Source & Reference

dbAMP

Other

(MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
6.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3
Evidence 7 Activity

Activity

MIC
Antifungal
6.2 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP CAFPdb

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 2
Evidence 8 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

S. aeurus

Source & Reference

dbAMP CAFPdb

Other

active against Gram- E. coli (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 9 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb

Other

li (MIC 6.2 ug/ml), P. aeruginosa (MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 10 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

F. solani

Source & Reference

dbAMP CAFPdb

Other

(MIC 6.2 ug/ml), Gram+ S. aeurus (MIC 3.1 ug/ml), fungi C. albicans (MIC 3.1 ug/ml), and F. solani (MIC 25 ug/ml).
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
400 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 400 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms. | Biochem Biophys Res Commun | 2010
Evidence 12 Activity

Activity

IC50
Toxicity
43±16 µM
Cytotoxic
IC50 | 43±16 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators. | Int J Antimicrob Agents | 2019
Evidence 13 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Antimicrob Agents. 2019 Jun 53(6):868-872.
Evidence 14 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis